{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":20,"n_cols":5,"rows_kept":20,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[4,2,4,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[12,2,12,3],[13,2,13,3],[16,2,16,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910829819503321"]
[null,null,"Titolo",null,"Cancer Consult . Volume 2. : Expertise in Clinical Practice / / edited by Syed A. Abutalib [and three others]"]
[null,null,"Pubbl/distr/stampa",null,"Chichester, England : , : John Wiley & Sons Ltd, , [2024]"]
[{"$nulls":4},"©2024"]
[null,null,"ISBN",null,"1-119-82319-6"]
[{"$nulls":4},"1-119-82320-X"]
[null,null,"Edizione",null,"[Second edition.]"]
[null,null,"Descrizione fisica",null,"1 online resource (863 pages)"]
[null,null,"Disciplina",null,"616.99/418"]
[null,null,"Soggetti",null,"Hematopoietic system - Cancer"]
[{"$nulls":4},"Hematological oncology"]
[{"$nulls":4},"Cellular therapy"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Includes index."]
[null,null,"Nota di contenuto",null,"Intro -- Cancer Consult -- Contents -- Editors Volume 2 -- Preface -- Author Bios -- Acknowledgement -- Part 1 Acute Lymphoblastic Leukemia in Adults -- 1 Prognostic Markers and Models in Acute Lymphoblastic Leukemia -- 2 Acute Lymphoblastic Leukemia-Treatment and Outcomes in B-ALL -- 3 T Cell Acute Lymphoblastic Leukemia and Acute Lymphoblastic Lymphoma -- 4 Minimal Residual Disease in Acute Lymphoblastic Leukemia -- 5 Hematopoietic Transplantation and Cellular Therapy in Acute Lymphoblastic Leukemia -- Part 2 Acute Myeloid Leukemia in Adults -- 6 Prognosis in Acute Myeloid Leukemia: Beyond Cytogenetics -- 7 Young Adults with Acute Myeloid Leukemia -- 8 Older Adults with Acute Myeloid Leukemia -- 9 Acute Promyelocytic Leukemia -- 10 Measurable Residual Disease in Acute Myeloid Leukemia -- 11 Hematopoietic Cell Transplantation and Cellular Therapy in Acute Myeloid Leukemia -- Part 3 Myelodysplastic Syndromes and Familial Myeloid Neoplasms -- 12 Diagnosis of Myelodysplastic Syndromes -- 13 Treatment of Myelodysplastic Syndromes -- 14 Hematopoietic Cell Transplantation and Cellular Therapy in Myelodysplastic Syndromes -- 15 Familial Myeloid Neoplasms-When to Suspect and What to Do? -- Part 4 Myeloproliferative Neoplasms -- 16 Chronic Myeloid Leukemia: Chronic Phase Disease -- 17 Chronic Myeloid Leukemia: Advance Phases of the Disease -- 18 Chronic Myeloid Leukemia: Treatment Safety During "]
[{"$nulls":4},"Reproductive Age and Pregnancy -- 19 Chronic Myeloid Leukemia: Cessation of Therapy -- 20 Hematopoietic Cell Transplantation in Chronic Myeloid Leukemia -- 21 Polycythemia Vera -- 22 Essential Thrombocythemia -- 23 Primary Myelofibrosis -- 24 Hematopoietic Cell Transplantation and Cellular Therapy in Primary and Post ET/PV Myelofibrosis -- 25 Chronic Myelomonocytic Leukemia -- 26 Eosinophilic Myeloproliferative Disorders."]
[{"$nulls":4},"Part 5 Chronic Lymphocytic and Other Leukemias -- 27 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma -- 28 Hematopoietic Cell Transplantation and Cellular Therapy in Chronic Lymphocytic Leukemia -- 29 Prolymphocytic Leukemia -- 30 Hairy Cell Leukemia -- Part 6 Hodgkin Lymphoma -- 31 Classic Hodgkin Lymphoma -- 32 Nodular Lymphocyte-Predominant Hodgkin Lymphoma -- 33 Hematopoietic Cell Transplantation and Cellular Therapy in Hodgkin Lymphoma -- Part 7 Non-Hodgkin's Lymphomas -- 34 Pitfalls in the Diagnosis of Non-Hodgkin's Lymphomas -- 35 Follicular Lymphoma -- 36 Mantle Cell Lymphoma -- 37 Marginal Zone Lymphoma -- 38 Hematopoietic Cell Transplantation and Cellular Therapy in Indolent Non-Hodgkin's Lymphomas -- 39 Diffuse Large B Cell Lymphoma -- 40 Hematopoietic Cell Transplantation and Cellular Therapy in Diffuse Large B Cell Lymphoma -- 41 Primary Mediastinal Large B Cell Lymphoma -- 42 Double-Hit and Double-Expressor Lymphomas -- 43 Transformed Lymphoma -- 44 Burkitt Lymphoma -- 45 Primary and Secondary CNS Lymphomas -- 46 HIV-Associated Lymphoma -- 47 Waldenström's Macroglobulinemia -- 48 Primary Cutaneous Lymphomas -- 49 Mycosis Fungoides and Sézary Syndrome -- 50 Peripheral T-Cell Lymphoma -- Part 8 Plasma Cell Neoplasms and Related Disorders -- 51 Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma -- 52 Risk Stratification Including Measurable Residual Disease in Multiple Myeloma -- 53 Newly Diagnosed Multiple Myeloma: Transplant Eligible -- 54 Newly Diagnosed Multiple Myeloma: Transplant Ineligible -- 55 Relapsed/Refractory Multiple Myeloma -- 56 Light-chain (AL) Amyloidosis -- 57 Bispecific T Cell Engager and Cell Based Immune Therapy in Multiple Myeloma -- Part 9 Special Issues in Neoplastic Hematology and Cellular Therapy -- 58 Treatment of Lymphomas During Pregnancy."]
[{"$nulls":4},"59 Complications and Management of CAR T Cell Therapy -- 60 Acute Graft-versus-Host Disease -- 61 Chronic Graft-versus-Host Disease -- Index -- EULA."]